TY - JOUR
T1 - Relationships between serum antioxidant and oxidant statuses and visual function in retinitis pigmentosa
AU - Ishizu, Masataka
AU - Murakami, Yusuke
AU - Fujiwara, Kohta
AU - Funatsu, Jun
AU - Shimokawa, Shotaro
AU - Nakatake, Shunji
AU - Tachibana, Takashi
AU - Hisatomi, Toshio
AU - Koyanagi, Yoshito
AU - Akiyama, Masato
AU - Momozawa, Yukihide
AU - Ishibashi, Tatsuro
AU - Sonoda, Koh Hei
AU - Ikeda, Yasuhiro
N1 - Funding Information:
Supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 16H06268 and 19K09952 (YM), The Uehara Memorial Foundation Grant (YM), The Kaibara Morikazu Medical Science Promotion Foundation Grant (YM), the Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder (YM), and the Bayer Retina Award (YI).
Publisher Copyright:
Copyright 2019 The Authors
PY - 2019/10/1
Y1 - 2019/10/1
N2 - PURPOSE. To investigate the serum changes of antioxidant/oxidant markers and the relationship between these factors and visual function in patients with retinitis pigmentosa (RP). METHODS. Fifty-two RP patients <40 years old and 25 controls were included. Serum samples were analyzed for superoxide dismutase 3 (SOD3) activity, glutathione peroxidase (GPx), potential antioxidant (PAO), and hexanoyl-lysine (HEL). The relationships between these markers and visual parameters, including best-corrected visual acuity (BCVA), mean deviation (MD), and average retinal sensitivity of 4 or 12 central points on static perimetry tests (Humphrey Field Analyzer, the central 10–2 program) were examined in the RP patients. RESULTS. Although there was no significant difference in the serum SOD3 activity between RP patients and controls, serum SOD3 activity in the severe degeneration group with macular involvement (16.3 6 11.3 U/mL) was significantly lower compared with those in the mild degeneration group (those with midperipheral scotomas; 28.5 6 16.6 U/mL, P ¼ 0.0459). SOD3 was significantly related to visual acuity (r ¼ -0.3701, P ¼ 0.0069) and the average retinal sensitivity of four central points (r ¼ 0.3463, P ¼ 0.0137) in RP patients. The linear trends of these two parameters across SOD3 levels were also significant (P ¼ 0.0264 and 0.0172, respectively). There was no consistent correlation between other serum antioxidant/ oxidant markers and visual parameters. CONCLUSIONS. Lower serum SOD3 activity was associated with the severe retinal degeneration in RP patients. Our results suggest that serum SOD3 activity may be related to disease severity in RP.
AB - PURPOSE. To investigate the serum changes of antioxidant/oxidant markers and the relationship between these factors and visual function in patients with retinitis pigmentosa (RP). METHODS. Fifty-two RP patients <40 years old and 25 controls were included. Serum samples were analyzed for superoxide dismutase 3 (SOD3) activity, glutathione peroxidase (GPx), potential antioxidant (PAO), and hexanoyl-lysine (HEL). The relationships between these markers and visual parameters, including best-corrected visual acuity (BCVA), mean deviation (MD), and average retinal sensitivity of 4 or 12 central points on static perimetry tests (Humphrey Field Analyzer, the central 10–2 program) were examined in the RP patients. RESULTS. Although there was no significant difference in the serum SOD3 activity between RP patients and controls, serum SOD3 activity in the severe degeneration group with macular involvement (16.3 6 11.3 U/mL) was significantly lower compared with those in the mild degeneration group (those with midperipheral scotomas; 28.5 6 16.6 U/mL, P ¼ 0.0459). SOD3 was significantly related to visual acuity (r ¼ -0.3701, P ¼ 0.0069) and the average retinal sensitivity of four central points (r ¼ 0.3463, P ¼ 0.0137) in RP patients. The linear trends of these two parameters across SOD3 levels were also significant (P ¼ 0.0264 and 0.0172, respectively). There was no consistent correlation between other serum antioxidant/ oxidant markers and visual parameters. CONCLUSIONS. Lower serum SOD3 activity was associated with the severe retinal degeneration in RP patients. Our results suggest that serum SOD3 activity may be related to disease severity in RP.
UR - http://www.scopus.com/inward/record.url?scp=85074233000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074233000&partnerID=8YFLogxK
U2 - 10.1167/iovs.19-26927
DO - 10.1167/iovs.19-26927
M3 - Article
C2 - 31658354
AN - SCOPUS:85074233000
SN - 0146-0404
VL - 60
SP - 4462
EP - 4468
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
IS - 13
ER -